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In stent restenosis (ISR) is a heterogeneous phenomenon. The
classical paradigm is neointimal proliferation in response to
vessel wall injury often in combination with incomplete stent ex-
pansion. Drug-eluting stents (DES) have been designed to reduce
or eliminate hyperplasia and in fact dramatically reduced restenosis
and target lesion revascularization (TLR). The drawback of DES has
been an increase in late and very late stent thrombosis, a potential-
ly life-threatening complication considered a consequence of
delayed and incomplete strut endothelialization.
The article of Habara et al.1 challenges this concept by analysing
in-stent restenosis with optical coherence tomography (OCT) in
the first generation DES at different time intervals from the im-
plantation. In this study of 86 sirolimus-eluting Cypher and
paclitaxel-eluting Taxus stents ISR they described different neointi-
mal patterns and assessed their prevalence at various time intervals
from DES implantation. They demonstrated that restenotic tissue
changes its characteristics over time. In the first months after im-
plantation a speckled pattern is frequent and they hypothesized
this was caused by proteoglycan deposition and delayed arterial
healing. Later after implantation neoatherosclerosis develops with
a pattern of thin-cap fibroatheroma (TCFA) observed in .10%
of 1–3 years old ISR and .30% IRS older than 3 years, some
with plaque rupture and thrombus formation. The majority of
these patients was identified with elective angiography and since
restenosis is rare also in first generation DES they had to
perform control angiography in 2666 patients to identify 91eligible
ISR patients.
Stent neoatherosclerosis has been described more than a
decade ago but the reports were dismissed as non-clinically rele-
vant anectodical findings till a growing series of OCT and path-
ology studies suggested that this was a frequent mode of failure
of bare metal stent (BMS) and first generation DES. A histopatho-
logical study on autoptic specimens by Nakazawa et al. 2 found that
the incidence of neoatherosclerosis was higher and occurred
earlier in DES compared with BMS. In particular, foamy macro-
phage clusters and TCFAs were found more frequently in DES
(14 and 13% within 2 years) than in BMS.
The question that arises is why DESs accelerate the neoathero-
sclerotic process? Angioplasty and more specifically stent implant-
ation with its predictable neointimal coverage has been advocated
as a technique to achieve plaque sealing and passivate active ath-
erosclerotic plaques.3 Specific designs of very thin self-expanding
stents with low radial force were tested as prophylactic treatment
of thin-capped fibroatheromas at risk of rupture.4 Interventionalists
may accept that neotherosclerosis develops several years after
stent implantation but are puzzled and in denial of a radical accel-
eration of the same phenomenon stents are expected to cure and
prevent. Delayed healing with an incomplete dysfunctional endo-
thelium has been blamed as the cause of the increment in late
and very late stent thrombosis observed with first generation
DES. Possibly the same process of prolonged neointimal disruption
may facilitate macrophage infiltration and lipid accumulation, devel-
oping vulnerable plaques prone to rupture as early as 1–3 years
after stenting. We concentrated our prevention measures on
strengthening and prolonging the antiplatelet treatment. If the
mechanism is more complex than persistence of bare struts in
contact with blood we may need to rethink our approach. How
frequent is the phenomenon? Ten to thirty per cent of the very
few DES that failed and develop restenosis in Habara’s study
may look trivial but still represents a significant percentage which
may grow for IRS occurring 5–10 years post-implantation. We
always consider ISR a stable process and the first reaction when
we find a borderline significant narrowing is to assess functional se-
verity with FFR. Maybe we should change our attitude, image them
with OCT5 and, if we find high-risk patterns, have a more liberal
approach to treatment, as the Authors actually did in this study
and as we normally do for lesions in saphenous vein grafts,
prone to rapid progression and occlusion. Is the phenomenon spe-
cific of the first generation DES? The characteristics of the poly-
mers and platforms radically differentiate stent performance and
the lower incidence of restenosis, stent thrombosis, and mortality
with the second generation vs. the first generation DES is reassur-
ing.6 Still we may need to wait few years from the introduction of
second generation DES in Japan and another careful OCT Japanese
follow-up serial study to have this important answer.
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Diastolic fluttering of the aortic valve: pathognomonic M-mode features
of flail cusp
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An 85-year-old woman presented with recent-
onset dyspnoea and fatigue, blood pressure of
120/45 mm Hg, diastolic thrill on the left
sternal border, and grade V/VI, high-frequency
harsh (buzzing) holodiastolic murmur radiating
to shoulder, spine, and vertex of the head. Two-
dimensional (2D) (Panel A, see Supplementary
data online, Video S1), three-dimensional (3D)
(Panel B, see Supplementary data online, Video
S2), colour-flow Doppler (Panel C, see Supple-
mentary data online, Video S3), and M-mode
transthoracic and transoesophageal echocardio-
graphic images revealed severe aortic regurgita-
tion due to an unsupported non-coronary flail
cusp with high-frequency diastolic flutter, and
diastolic aortic wall flutter responsible for the
murmur’s transmission to the upper torso
(Panel D). Surgery confirmed the flail cusp.
Pathology showed myxoid degeneration with
no endocarditis. Flail aortic valve leaflet results
in pathognomonic high-frequency diastolic flutter of the torn aortic cusp and occasionally of the aortic walls. This condition is best
demonstrated by M-mode echocardiography because of its higher temporal resolution than other imaging modalities including
2D/3D echocardiography, computed tomography, and magnetic resonance imaging.
Supplementary data are available at European Heart Journal – Cardiovascular Imaging online.
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